Medik8 Crystal Retinal 6 review: a named strength and a defined study

The US product description presents Crystal Retinal as a facial night serum in a 1.0 fl. oz. tube. Its selector includes 1, 3, 6, 10, 20 and 24. The reviewed preparation is number 6, which the manufacturer separately identifies as 0.06% retinaldehyde. The number in the name and the percentage should therefore appear together.

The range is useful for locating the product, but it does not make this review a strength-selection guide. In particular, evidence attached to number 6 cannot automatically describe every higher or lower option. The A-Game 5 review offers a separate product record for readers comparing retinal descriptions.

Medik8 provides separate complete lists under the names of its ladder options. The Crystal Retinal 6 declaration includes retinal alongside glycerin, squalane, sodium hyaluronate and tocopheryl acetate. It also names botanical extracts, coumarin and color ingredients. Reading that complete list is more informative than identifying retinal alone or borrowing the list printed under another strength.

An ingredient’s appearance establishes its declared presence, not its share of the formula or its contribution to an outcome. The public percentage concerns retinaldehyde; the rest of the declaration does not supply a concentration for each component. It also cannot show how the formula would behave alongside someone’s existing prescription or other products.

The results footnote names one tube of Crystal Retinal 6, 33 participants and 12 weeks. The page reports a 20% reduction in wrinkle appearance, a 20% reduction in visible dark spots and an 11% increase in firmness. Separately, 97% felt their skin looked more youthful and 100% felt the serum was gentle on their skin.

Those distinctions deserve to survive a short product summary. The two “felt” findings describe participants’ impressions; the other figures are presented as changes in appearance or firmness. The summary does not provide the full report, comparator or detailed measurement methods. Our photo evidence discussion explains why a visible change still needs context.

The prominent claim that retinal acts up to eleven times faster than retinol points to a 1990 paper on retinol and retinal metabolism. It is not the footnote for the 33-person finished-serum study. A biochemical conversion comparison is a different endpoint from the amount or speed of wrinkle improvement in people using this tube.

The AAD’s retinoid explanation also distinguishes the vitamin A family from its individual members, including over-the-counter retinol and prescription tretinoin. That context helps keep an ingredient explanation from becoming a prescription-substitution claim. The RENOVA label guide concerns a different, specifically labeled preparation and cannot validate Crystal Retinal 6.

The manufacturer’s ingredient discussion describes glycerin as helping retain moisture, hyaluronic acid as attracting water and vitamin E as nourishing the complexion. These are reasons for the supporting formula, rather than a controlled demonstration that one component caused the study’s comfort response. The complete list supplies another view of the same finished serum.

The AAD’s wrinkle guidance notes that moisturization can soften the appearance of some fine lines. That is useful background for a serum combining an active with moisture-supporting ingredients, without confirming Medik8’s percentages. Readers exploring a different formulation question can follow the Naturium review; neither record establishes a clinical winner.

In its packaging FAQ, Medik8 says a changed package does not mean the Crystal Retinal formula, ingredients or results changed. Elsewhere, its ingredient-list caveat allows for upgrades and slight regional variations, identifying the printed package list as definitive. One statement concerns the described packaging update; the other concerns the ongoing accuracy of website declarations.

These statements can be reported together without assuming that every tube sold in every market is analytically identical. This review concerns the US record and the list headed Crystal Retinal 6. It does not verify a purchased batch, establish the contents of an older package or reconcile an individual container with every version of the website.

The useful evidence is a named retinal strength with a defined participant count and duration, supported by a strength-specific declaration. The same record leaves important questions about comparison, measurement and individual variation. Its “Earn $56.00 points” display is reward-program wording, so it should not be presented as the purchase price of Crystal Retinal 6.

The FDA’s category explanation separates appearance-related cosmetic purposes from drug claims according to intended use. It does not certify this serum’s results. Our fine-line options comparison provides a wider set of records while preserving the difference between a retail appearance claim and evidence for an exact prescription product.